In my sixth year of Parkinson's, cognitive changes leave me wondering how much of this decline is due to the disease and how ...

Parkinson's disease occurs when brain cells that produce an important hormone called dopamine begin to die off or become ...

Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

In the first part of the club's tour diary, Wrexham's manager reveals how he has prepared for the visit to Australia and New ...

People with Parkinson’s often stay silent about their diagnosis. Here’s what drives that silence and why understanding it ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

The findings of two recent studies give hope that the disease could one day be reversed in humans—but experts warn that this ...

A progressive neurological disorder affecting 10 million people globally, Parkinson’s can cause disruptive symptoms such as ...

A recent phase 2 clinical trial reveals that Ambroxol, a common cough medicine, shows promise in stabilizing psychiatric ...

A new study reveals that which side of the body is initially affected by Parkinson's disease can predict cognitive decline ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...